CTI BioPharma Corp. (CTIC)
NASDAQ: CTIC
· Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM
CTI BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -69.24M | -92.99M | -112.32M | -120.8M | -117.82M | -97.91M | -76.12M | -63.21M | -57.53M |
Depreciation & Amortization | 2.15M | 1.95M | 1.55M | 1.15M | 708K | 526K | 528K | 529K | 534K |
Stock-Based Compensation | 10.85M | 10.03M | 7.04M | 4.22M | 1.68M | n/a | n/a | n/a | n/a |
Other Working Capital | 16.48M | -6.25M | 933K | 3.41M | 107K | 270K | 8.46M | 8.46M | 8.46M |
Other Non-Cash Items | 9.86M | 7.74M | 5.07M | 2.85M | 546K | -113K | 4.12M | 4.05M | 7.76M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -4.2M | -4.2M | -4.2M |
Change in Working Capital | -35.94M | -7.92M | 1.5M | 9.01M | 12.98M | 7.86M | 5.78M | 2.19M | 817K |
Operating Cash Flow | -82.31M | -81.19M | -95.7M | -100.74M | -98.09M | -84.89M | -65.69M | -56.57M | -48.54M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -17K | -17K | -17K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -73.81M | -59.06M | -29.6M | n/a | n/a | n/a | n/a | -12.1M | -12.1M |
Sales Maturities Of Investments | 70M | 40M | 10M | n/a | 4M | 12M | 12M | 12M | 8M |
Other Investing Acitivies | -25M | -25M | -54.79M | -54.79M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -58.6M | -73.85M | -74.39M | -54.79M | 4M | 12M | 11.98M | -117K | -4.12M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 24M | 75.8M | 62.64M | 105.52M | 157.89M | 97.94M | 103.68M | 58.45M | 4.61M |
Financial Cash Flow | 68.22M | 120.02M | 106.86M | 149.74M | 157.89M | 97.94M | 103.68M | 58.45M | 4.61M |
Net Cash Flow | -72.69M | -35.03M | -63.23M | -5.79M | 63.8M | 25.05M | 49.98M | 1.77M | -48.04M |
Free Cash Flow | -82.31M | -81.19M | -95.7M | -100.74M | -98.09M | -84.89M | -65.71M | -56.58M | -48.56M |